Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

World Health O. Therapeutics and COVID-19: living guideline, 31 March 2021. 2021.

Guney C, Akar F. Epithelial and endothelial expressions of ACE2: SARS-CoV-2 entry routes. J Pharm Pharm Sci. 2021;24:84–93.

Article  CAS  PubMed  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80 e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122–7.

Article  CAS  PubMed  Google Scholar 

Nicolai L, Kaiser R, Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J Thromb Haemost. 2023;21(8):2020–31.

Article  PubMed  Google Scholar 

Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D’Anna SE, Bachetti T, et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10(4):812.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Rooij L, Becker LM, Carmeliet P. A role for the vascular endothelium in post-acute COVID-19? Circulation. 2022;145(20):1503–5.

Article  PubMed  Google Scholar 

Evans PC, Rainger GE, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. 2020;116(14):2177–84.

Article  CAS  PubMed  Google Scholar 

Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. 2022;140(3):222–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishijima Y, Hader SN, Hanson AJ, Zhang DX, Sparapani R, Gutterman DD, et al. Prolonged endothelial-dysfunction in human arterioles following infection with SARS-CoV-2. Cardiovasc Res. 2022;118(1):18–9.

Article  CAS  PubMed  Google Scholar 

Oikonomou E, Souvaliotis N, Lampsas S, Siasos G, Poulakou G, Theofilis P, et al. Endothelial dysfunction in acute and long standing COVID-19: a prospective cohort study. Vasc Pharmacol. 2022;144:106975.

Article  CAS  Google Scholar 

Peng M, He J, Xue Y, Yang X, Liu S, Gong Z. Role of hypertension on the severity of COVID-19: a review. J Cardiovasc Pharmacol. 2021;78(5):e648–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shibata S, Kobayashi K, Tanaka M, Asayama K, Yamamoto E, Nakagami H, et al. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19. Hypertens Res. 2023;46(3):589–600.

Article  PubMed  Google Scholar 

Ingraham NE, Barakat AG, Reilkoff R, Bezdicek T, Schacker T, Chipman JG, et al. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur Respir J. 2020;56(1):2000912.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang J, Wang M, Ding W, Wan J. The interaction of RAAS inhibitors with COVID-19: current progress, perspective and future. Life Sci. 2020;257:118142.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tadic M, Saeed S, Grassi G, Taddei S, Mancia G, Cuspidi C. Hypertension and COVID-19: ongoing controversies. Front Cardiovasc Med. 2021;8:639222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gallo G, Calvez V, Savoia C. Hypertension and COVID-19: current evidence and perspectives. High Blood Press Cardiovasc Prev. 2022;29(2):115–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Savoia C, Volpe M, Kreutz R. Hypertension, a moving target in COVID-19: current views and perspectives. Circ Res. 2021;128(7):1062–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Writing Committee for the R-CAPI, Lawler PR, Derde LPG, van de Veerdonk FL, McVerry BJ, Huang DT, et al. Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19: a randomized clinical trial. JAMA. 2023;329(14):1183–96.

Bessa J, Albino-Teixeira A, Reina-Couto M, Sousa T. Endocan: a novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clin Chim Acta. 2020;509:310–35.

Article  CAS  PubMed  Google Scholar 

Reina-Couto M, Silva-Pereira C, Pereira-Terra P, Quelhas-Santos J, Bessa J, Serrao P, et al. Endothelitis profile in acute heart failure and cardiogenic shock patients: endocan as a potential novel biomarker and putative therapeutic target. Front Physiol. 2022;13:965611.

Article  PubMed  PubMed Central  Google Scholar 

Gorgun S, Cindoruk S, Ozgen E, Yadigaroglu M, Demir MT, Yucel M, et al. Diagnostic and prognostic value of serum endocan levels in patients with COVID-19. Angiology. 2021;72(10):942–6.

Article  CAS  PubMed  Google Scholar 

Medetalibeyoglu A, Emet S, Kose M, Akpinar TS, Senkal N, Catma Y, et al. Serum endocan levels on admission are associated with worse clinical outcomes in COVID-19 patients: a pilot study. Angiology. 2021;72(2):187–93.

Article  CAS  PubMed  Google Scholar 

Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care. 2021;25(1):166.

Article  PubMed  PubMed Central  Google Scholar 

Frerou A, Lesouhaitier M, Gregoire M, Uhel F, Gacouin A, Reizine F, et al. Venoarterial extracorporeal membrane oxygenation induces early immune alterations. Crit Care. 2021;25(1):9.

Article  PubMed  PubMed Central  Google Scholar 

Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20(1):387.

Article  PubMed  PubMed Central  Google Scholar 

Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest. 2010;40(1):35–53.

Article  CAS  PubMed  Google Scholar 

Keskinidou C, Vassiliou AG, Zacharis A, Jahaj E, Gallos P, Dimopoulou I, et al. Endothelial, immunothrombotic, and inflammatory biomarkers in the risk of mortality in critically ill COVID-19 patients: the role of dexamethasone. Diagnostics (Basel). 2021;11(7):1249.

Article  CAS  PubMed  Google Scholar 

Liu N, Long H, Sun J, Li H, He Y, Wang Q, et al. New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression. J Med Virol. 2022;94(7):3112–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oliva A, Rando E, Al Ismail D, De Angelis M, Cancelli F, Miele MC, et al. Role of serum E-selectin as a biomarker of infection severity in coronavirus disease 2019. J Clin Med. 2021;10(17):4018.

Article  CAS  PubMed  PubMed Central